Eplerenone is a selective aldosterone receptor blocker, which means it has a lower affinity for androgen and progesterone receptors. This selectivity reduces the risk of hormonal side effects such as gynecomastia and menstrual irregularities that are more common with spironolactone.
Yes. Eplerenone’s efficacy does not depend on dietary sodium intake, but a low-sodium diet can enhance overall blood-pressure control. Continue to follow any dietary recommendations given by your healthcare professional.
Eplerenone does not have a direct effect on lipid metabolism. Routine cholesterol monitoring should continue as part of your overall cardiovascular risk management, but the medication itself is not expected to raise or lower cholesterol.
Eplerenone is a prescription-only medication in the UK and most other countries. Carry the original prescription label, a copy of the prescribing information, and keep the tablets in your hand luggage to avoid temperature extremes and loss.
Symptoms of significant hyperkalaemia include muscle weakness, fatigue, irregular heartbeats, or a tingling sensation around the mouth. However, many cases are asymptomatic and are identified through routine blood tests, so regular monitoring is essential.
Some herbal products, such as those containing St. John’s Wort (a CYP3A4 inducer) or Licorice (which can raise aldosterone-like activity), may interfere with eplerenone’s effectiveness or increase potassium levels. Discuss any supplements with your pharmacist.
No. Using a salt substitute that contains potassium can significantly raise serum potassium when combined with eplerenone. Choose a non-potassium alternative and consult your clinician for suitable options.
If you remember the missed dose within 12 hours, take it. If it is closer to the time of your next scheduled dose, skip the missed tablet and continue with your regular dosing schedule. Do not double the dose.
Eplerenone is not known to cause visual disturbances. If you experience sudden changes in vision, seek medical attention promptly, as this may be unrelated to the medication.
Most patients notice a modest reduction in blood pressure within 1-2 weeks, but the full therapeutic effect may require 4-6 weeks of consistent dosing and dose titration, if needed.
Eptus contains eplerenone as its active component. Eplerenone belongs to the class of aldosterone antagonists and is used to manage conditions related to the heart and blood pressure. The medication is supplied as a pill in a 25 mg strength. In the United Kingdom, eplerenone-containing products are prescription-only medicines regulated by the Medicines and Healthcare products Regulatory Agency (MHRA).
Eplerenone blocks the mineralocorticoid (aldosterone) receptor in the distal tubules of the kidney. By preventing aldosterone from binding, the drug reduces sodium reabsorption and promotes potassium retention. The resulting shift in fluid balance lowers blood volume and pressure, and lessens the strain on the heart. Because eplerenone is selective for the aldosterone receptor, it produces fewer hormonal side effects than older, non-selective agents such as spironolactone.
Eplerenone is approved in the UK for the following indications:
These approvals are based on large clinical trials that demonstrated reductions in cardiovascular mortality and hospitalisation for heart-failure patients.
At present, there is no high-quality, peer-reviewed evidence that supports routine off-label use of eplerenone for other conditions. Any consideration of unapproved indications should be undertaken only under the direct supervision of a qualified healthcare professional, with a clear assessment of potential risks and benefits.
This article provides educational information about Eptus and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
